Creso Pharma Limited
OTC: COPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- William Lay
- Headquarters
- Nedlands, Australia
- IPO year
- 2017
- Market cap
- $131.7M
- Website
- https://www.cresopharma.com
Loading COPHF…
Loading profile data…Frequently asked questions about COPHF
What does Creso Pharma Limited (COPHF) do?
Creso Pharma Limited is a global pharmaceutical company focused on the development, registration, and commercialization of advanced cannabis and hemp-based solutions. These therapeutic products and nutraceuticals are designed for both human and animal health applications, with market presence spanning Europe, the Middle East, North America, and...
Where does COPHF trade?
Creso Pharma Limited (COPHF) trades on the Other OTC.
What sector is COPHF in?
Creso Pharma Limited (COPHF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Creso Pharma Limited?
William Lay is the chief executive officer of Creso Pharma Limited (COPHF).
Where is Creso Pharma Limited headquartered?
Creso Pharma Limited is headquartered in Australia.
Does COPHF pay a dividend?
Creso Pharma Limited (COPHF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did COPHF go public?
Creso Pharma Limited (COPHF) completed its initial public offering in 2017.